Early Aortic Valve Lipoprotein(a) Lowering Trial

NCT02109614 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Aortic Stenosis and Lipoprotein(a) Levels

Interventions

DRUG: Extended release Niacin
DRUG: Placebo Comparator

Sponsor

George Thanassoulis

Collaborators

[object Object]
[object Object]
[object Object]